From: High mitochondria content is associated with prostate cancer disease progression
 | No. of patients | |
---|---|---|
 | Study cohort on tissue microarray (n = 11,152) | Biochemical relapse among categories (n = 1,824) |
Follow-up (mo) | Â | Â |
Mean | 53.4 | Â |
Median | 36.8 | Â |
Age (y) | Â | Â |
<50 | 318 | 49 |
50-60 | 2.77 | 460 |
60-70 | 6.55 | 1.08 |
>70 | 1.44 | 232 |
Pretreatment PSA (ng/ml) | Â | Â |
<4 | 1.41 | 142 |
4-10 | 6,735 | 827 |
10-20 | 2,159 | 521 |
>20 | 720 | 309 |
pT category (AJCC 2002) | Â | Â |
pT2 | 7.370 | 570 |
pT3a | 2.41 | 587 |
pT3b | 1.26 | 618 |
pT4 | 63 | 49 |
Gleason grade | Â | Â |
≤3 + 3 | 2.86 | 193 |
3 + 4 | 1.57 | 573 |
4 + 3 | 6.18 | 849 |
≥4 + 4 | 482 | 208 |
pN category | Â | Â |
pN0 | 6.12 | 1.13 |
pN+ | 561 | 291 |
Surgical margin | Â | Â |
Negative | 8.98 | 1.15 |
Positive | 1.970 | 642 |